Let's talk about a topic that's often overlooked despite its immense importance: the incredible progress we've made in medical innovation and its profound impact on our lives. I'm here to shed light on this often-overlooked aspect of our modern world.
The Power of Medical Innovation
Imagine a world without medical breakthroughs. A world where a heart attack meant certain death, where diabetes was a death sentence, and where a simple wound could lead to fatal sepsis. Thankfully, we've come a long way, and it's time to appreciate the magnitude of this progress.
A Glimpse into the Past
In the 1950s, if you suffered a heart attack, the odds were stacked against you. CPR was yet to be invented, and the prevailing belief was that once the heart stopped, there was no turning back. Fast forward to today, and we've witnessed a remarkable transformation. The survival rate for the most severe heart attacks has improved by a staggering two-thirds. This progress isn't limited to heart disease; cardiovascular diseases as a whole have seen a dramatic decline in mortality rates.
The Impact on Life Expectancy
The improvements in medical care have added years, sometimes even decades, to people's lives. What's even more remarkable is that this progress has reduced inequality in life expectancy. The gains have been greatest among those who would have previously died as children or young adults. Life expectancy has increased across all age groups, meaning fewer parents lose their children, fewer siblings are left behind, and we grow old with more of our loved ones by our side.
A Technological Revolution
I used to think medical breakthroughs were rare occurrences, but I've come to realize that medical innovation is a continuous stream of progress. In recent years alone, we've seen remarkable advancements. New antiviral drugs against HIV with nearly 100% efficacy, drugs that reduce cholesterol levels by 60% for those already on statins, and treatments that slow the progression of various cancers by more than half. We've even developed vaccines for diseases like COVID-19, malaria, and RSV.
The Science Behind the Success
The progress we've made is a result of scientific advancements and a better understanding of diseases and their treatments. Chemistry, once a young discipline, has matured, allowing us to isolate and synthesize compounds, and screen them for medical effects. This systematic approach has led to the discovery of antibiotics, statins, and immunosuppressants. The development of 'rational drug design' has further accelerated this process, enabling scientists to design molecules that fit into disease-driving proteins and block them.
AI: The Game Changer
Advances in AI have taken medical innovation to new heights. Tools like AlphaFold can predict protein shapes in minutes, a task that used to take years. AI is also being used to design entirely new proteins, including enzymes that target cancer cells and destroy disease-causing proteins. These tools are uncovering hidden microbial genes that encode antibiotics and even ancient versions of CRISPR enzymes, offering new gene-editing capabilities.
The Role of Research and Development
Much of the early research behind these breakthroughs takes place in academic labs and institutes funded by governments and foundations. These institutions lay the foundation, and then pharmaceutical companies step in to develop, test, and bring these treatments to market. This process has transformed once-fatal diseases into manageable, and sometimes curable, conditions. Medical innovation is one of the most valuable aspects of a modern economy, with economists estimating that gains in life expectancy in the United States from 1970 to 2000 were worth a staggering $95 trillion to Americans.
Bottlenecks and Broken Incentives
Despite these incredible advancements, there are still effective treatments in the pipeline that may take years, if not decades, to reach patients. Take, for example, the malaria vaccine. The first malaria vaccine was developed in the 1990s, but it took decades to reach children in need due to a lack of commercial incentive and funding. This is a problem that extends beyond malaria. Tropical diseases like trachoma, leptospirosis, and mycetoma receive almost no R&D funding, and the research pipelines for these diseases are alarmingly narrow.
Solving the Incentive Problem
Economists have proposed an idea to change these incentives: advance market commitments. This strategy involves donors promising to buy a vaccine at a certain price per dose if it's developed and proven safe and effective. This commitment gives companies the confidence to invest and can bring vaccines into existence that might otherwise never get made. This approach has already been successfully used to develop new vaccines for pneumococcal disease, saving the lives of over 700,000 young children.
The Challenge of Rare Diseases
Rare diseases, affecting fewer than 1 in 2,000 people, present another challenge. Thousands of rare diseases have been described, collectively affecting up to 6% of the population, yet 95% of these diseases have no approved treatment. Running trials for these conditions requires innovative thinking, such as using smaller but more efficient trials and different approval pathways. For instance, regulatory systems could treat the delivery method of gene therapies as a single platform, allowing the genetic sequence to be switched to target different mutations or diseases without needing new approvals each time.
The Future of Medical Innovation
While we've made incredible progress, there's still much work to be done. Far too many diseases remain untreatable, and we need to move faster to solve these bottlenecks. Commercial incentives often lead firms to focus on diseases with large commercial markets, leaving many diseases with few patients or those affecting poorer countries neglected. We need new ideas and people to test, scale, and implement these ideas. Progress is possible, and we've seen it with conditions like hepatitis C, cervical cancer, and cystic fibrosis, which are now curable or preventable.
The Way Forward
The central drama of the modern world is the battle against suffering through innovation. We've made incredible progress, but we can do so much more. Millions still suffer from untreatable diseases due to bottlenecks that we can fix. It's time to change the processes that are bottlenecked by funding, institutions, and incentives. We need to find ways to make our resources go further and continue to innovate. The future of medical innovation is bright, and with the right support and incentives, we can make an even greater impact on global health.
